BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26468390)

  • 1. Pancreatic hyperplasia after gastric bypass surgery in a GK rat model of non-obese type 2 diabetes.
    Zhou X; Qian B; Ji N; Lui C; Liu Z; Li B; Zhou H; Yan C
    J Endocrinol; 2016 Jan; 228(1):13-23. PubMed ID: 26468390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of New Modified Biliopancreatic Diversion on Blood Glucose and Lipids in GK rats.
    Weng S; Zhang B; Xu C; Feng S; He H
    Obes Surg; 2017 Mar; 27(3):657-664. PubMed ID: 27525641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after roux-en-y gastric bypass surgery.
    Chai F; Wang Y; Zhou Y; Liu Y; Geng D; Liu J
    Obes Surg; 2011 Jun; 21(6):768-73. PubMed ID: 21240658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
    Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
    Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats.
    Zubiaga L; Abad R; Ruiz-Tovar J; Enriquez P; Vílchez JA; Calzada M; Pérez De Gracia JA; Deitel M
    Obes Surg; 2016 Nov; 26(11):2622-2628. PubMed ID: 26989061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression.
    Kong X; Tu Y; Li B; Zhang L; Feng L; Wang L; Zhang L; Zhou H; Hua X; Ma X
    Mol Metab; 2019 Nov; 29():1-11. PubMed ID: 31668381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta Cell Hyperplasia in Adult Goto-Kakizaki (GK/MolTac) Diabetic Rats.
    Alán L; Olejár T; Cahová M; Zelenka J; Berková Z; Smětáková M; Saudek F; Matěj R; Ježek P
    J Diabetes Res; 2015; 2015():385395. PubMed ID: 26236746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
    Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
    Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
    Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
    Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon secretion after metabolic surgery in diabetic rodents.
    Eickhoff H; Louro T; Matafome P; Seiça R; Castro e Sousa F
    J Endocrinol; 2014 Dec; 223(3):255-65. PubMed ID: 25274989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Glucose Tolerance and Pancreatic Beta Cell Function by Low Dose Aspirin in Hyperglycemic Insulin-Resistant Type 2 Diabetic Goto-Kakizaki (GK) Rats.
    Amiri L; John A; Shafarin J; Adeghate E; Jayaprakash P; Yasin J; Howarth FC; Raza H
    Cell Physiol Biochem; 2015; 36(5):1939-50. PubMed ID: 26202354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
    Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
    Martinussen C; Bojsen-Møller KN; Dirksen C; Jacobsen SH; Jørgensen NB; Kristiansen VB; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E535-44. PubMed ID: 25628424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
    Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
    Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of IRS-1 expression in Goto-Kakizaki rats following Roux-en-Y gastric bypass surgery: resolution of type 2 diabetes?
    Li SQ; Zhou Y; Wang Y; Liu Y; Geng DH; Liu JG
    Tohoku J Exp Med; 2011 Nov; 225(3):179-86. PubMed ID: 22001674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
    Sheikh S; Gudipaty L; De Leon DD; Hadjiliadis D; Kubrak C; Rosenfeld NK; Nyirjesy SC; Peleckis AJ; Malik S; Stefanovski D; Cuchel M; Rubenstein RC; Kelly A; Rickels MR
    Diabetes; 2017 Jan; 66(1):134-144. PubMed ID: 27495225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.